Aktienanalyse zu Lifeway Foods Inc (LWAY)LWAYLifeway Foods Inc

Lifeway Foods, Inc. is a supplier of the probiotic, fermented beverage known as Kefir. In addition to its line of drinkable Kefir, the Company also produces a variety of cheeses and a ProBugs line for kids. Its primary product is drinkable kefir, a cultured dairy product. Lifeway kefir is tart and tangy, high in protein, calcium and vitamin D. It manufactures products under the Lifeway, Fresh Made and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers. Its product categories are Drinkable kefir; European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss; Cream and others, which consist primarily of cream, a byproduct of making its kefir; Drinkable yogurt, sold in a variety of sizes and flavors; ProBugs, a line of kefir products designed for children, and Other dairy, which consists primarily of Fresh Made butter and sour cream. It operates in the Consumer Non-Cyclicals sector (DAIRY PRODUCTS industry).

Lifeway Foods Inc is currently a hold. The stock is priced at $22.46, with a forward P/E of 29.94, which indicates potential for growth but also suggests it may be overvalued based on earnings. The recent sell-offs by major shareholders, including a 20,000 share sale, have raised concerns about investor confidence, which could pressure the stock in the short term. However, the company reported a record Q2 sales growth of 24.1%, indicating strong demand for its products. The main risk is the declining gross margin, which fell to 19.27% in Q2 due to rising costs, impacting profitability.

1 analysts cover LWAY: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 35.00.